Single-channel and whole-cell analysis of ethanol inhibition of NMDA-activated currents in cultured mouse cortical and hippocampal neurons

Brain Research
J M WrightF F Weight

Abstract

The effects of 0.1 to 500 mM ethanol on NMDA-activated currents were studied in primary cultures of mouse cortical and hippocampal neurons. In whole-cell recordings the IC50S for inhibition of NMDA-activated currents by ethanol were 129 mM +/- 20 mM in hippocampal neurons and 126 +/- 18 mM in cortical neurons. In single-channel recordings from excised outside-out patches of cortical neurons, ethanol inhibited total charge per minute with an IC50 of 174 +/- 23 mM, which was not significantly different from the IC50S for inhibition of whole-cell current. The reduction in mean open channel lifetime by ethanol was fit by the logistic equation with an apparent IC50 of 340 +/- 28 mM. Analysis of single-channel data indicated that ethanol inhibition of NMDA currents did not involve substantial changes in fast closed state kinetics, changes in open channel conductance, or block of the open channel. At the whole-cell IC50 of ethanol, mean open channel lifetime would decrease by 28% and frequency of opening would decline by 31% to account for the reduction in current. Single-channel data were consistent with ethanol being an allosteric modulator of gating which reduces agonist efficacy.

References

Mar 1, 1992·Trends in Neurosciences·S A Lipton
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·N NakanishiN A Shneider
Mar 31, 1989·Science·D M LovingerF F Weight
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D T MonaghanC W Cotman
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
May 1, 1993·Neuron·C Rosenmund, G L Westbrook
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·R W Peoples, F F Weight
Mar 3, 1994·The New England Journal of Medicine·S A Lipton, P A Rosenberg

❮ Previous
Next ❯

Citations

Feb 15, 2001·Journal of Biomedical Science·K M Davis, J Y Wu
Sep 16, 1999·Cellular and Molecular Life Sciences : CMLS·M D Krasowski, N L Harrison
Apr 7, 2005·European Archives of Psychiatry and Clinical Neuroscience·Andre TadicMichael Soyka
Jan 4, 2001·Neurochemistry International·C T SmothersJ J Woodward
Jul 16, 1999·Neurochemistry International·J J Woodward
Jul 16, 1999·Neurochemistry International·F F WeightR W Peoples
Jul 16, 1999·Neurochemistry International·K WirknerP Illes
Oct 17, 1998·Progress in Neurobiology·F Fadda, Z L Rossetti
Feb 12, 1998·British Journal of Pharmacology·T IbbotsonP R Boden
Apr 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tianna R HicklinMichael D Browning
Jan 23, 2008·The Journal of Biological Chemistry·Hong RenRobert W Peoples
Oct 1, 2013·Journal of Addictive Diseases·Awoyemi A Awofala
Mar 9, 1999·Alcoholism, Clinical and Experimental Research·D L AndersJ J Woodward
Jan 8, 2011·The Journal of Pharmacology and Experimental Therapeutics·Olga OstrovskayaDaryl L Davies
Oct 19, 2011·The Journal of Pharmacology and Experimental Therapeutics·Minfu XuJohn J Woodward
Mar 10, 2009·Pharmacological Reviews·Alex M Dopico, David M Lovinger
Jun 12, 2010·Forensic Science International : Synergy·Ricardo Jorge Dinis-OliveiraAgostinho Santos
Dec 10, 2015·Cerebral Cortex·Julia LebedevaRoustem Khazipov
Jun 9, 2015·Neuropharmacology·Yulin ZhaoRobert W Peoples
Aug 3, 2013·Alcoholism, Clinical and Experimental Research·Corigan T SmothersJohn J Woodward
Mar 21, 2012·Basic & Clinical Pharmacology & Toxicology·Tommi Möykkynen, Esa R Korpi
Aug 19, 2015·Annals of the New York Academy of Sciences·Klaus A MiczekRosa M M de Almeida
Apr 9, 2005·Annals of the New York Academy of Sciences·Klaus A MiczekJoseph F Debold
Mar 15, 2005·British Journal of Pharmacology·Keming XiongChaoying Li
Jun 13, 2006·Biochemical Pharmacology·Tao A ZhangRichard A Morrisett
Jan 31, 2015·The Journal of Pharmacology and Experimental Therapeutics·Minfu XuJohn J Woodward
Aug 24, 2017·Alcoholism, Clinical and Experimental Research·Bo SöderpalmMia Ericson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.